Paul Jenn serves as Executive at LA JOLLA PHARMACEUTICAL CO, where they oversee executive responsibilities. Since joining the company, Paul Jenn has executed 9 insider transactions totaling $36.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 10, 2007 involved selling 6,630 shares valued at $20.5K.
Paul Jenn currently holds 350 shares of LA JOLLA PHARMACEUTICAL CO (LJPC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Jenn has been a net seller of LJPC stock. They have purchased $0 and sold $36.0K worth of shares.
Paul Jenn's most recent insider trade was on Jan 10, 2007, when they sold 6,630 shares at $3.09 per share.
Get notified when new Form 4 filings are submitted
| $2.58 |
| Discretionary |
| Dec 29, 2006 | LJPC | $15.6K | Sale | 5,000 | $3.11 | Discretionary |
| Dec 14, 2006 | LJPC | $4.7K | Disposition | 1,500 | $3.12 | Discretionary |
| Sep 30, 2006 | LJPC | $532 | Other | 174 | $3.06 | Discretionary |
| Aug 24, 2006 | LJPC | $0 | Gift | 1,819 | $N/A | Discretionary |
| Jun 30, 2006 | LJPC | $453 | Other | 148 | $3.06 | Discretionary |
| Mar 31, 2006 | LJPC | $532 | Other | 174 | $3.06 | Discretionary |
| Dec 31, 2005 | LJPC | $1.1K | Other | 363 | $3.06 | Discretionary |